BlueWillow Biologics® is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. The platform employs novel oil-in-water nano-droplets for products administered to the skin and nose.

The company was founded as a spin-off from the University of Michigan, and was initially focused on developing nano-scale dermatology applications. Based on promising research generated under several Gates Foundation, NIH and DOD contracts, BlueWillow’s technology has been advanced significantly in recent years yielding several therapies in development.

Biotechnology

BlueWillow Biologics

Chad Costley

Lawrence Black

��

BlueWillow Biologics

Org chart

Teams

Research and Development

Similar companies

��������

BlueWillow Biologics

Org chart

Teams

Research and Development

Similar companies

��